Pain medicine

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults

JAMA Netw OpenPublished Serial cross-sectional study

An erratum to this article was published (JAMA Netw Open, 3 Jul 2023 ↗)

Authors' conclusion

The findings of this cross-sectional study of Medicare beneficiaries suggest that new postoperative gabapentinoid prescribing increased without a subsequent downward trend in the proportion of patients receiving postoperative opioids and a near tripling of concurrent prescribing.

Study context

Population
Gabapentinoid-naive patients 66 years or older undergoing 1 of 14 common noncataract surgical procedures, US Medicare, 2013–2018
Participants
494,922 patients
Exposure
2014 vs 2018
Outcome
Rate of postoperative prescribing of gabapentinoids and opioids (prescription filled between 7 days before the procedure and 7 days after discharge from surgery)
Methodological details20% US Medicare sample, Data analyzed April 2022 to April 2023
  • 20% US Medicare sample
  • Data analyzed April 2022 to April 2023

Main finding

As reported in the abstract

New postoperative gabapentinoid prescribing (adjusted rate)

P < 0.001

Patients receiving a new gabapentinoid prescription postoperatively, overall
18 095 (3.7%)

Observational data: associations, not effects.

Further findings

Outcome20142018
Concomitant gabapentinoid and opioid prescribing1.6% (95% CI 1.5%–1.7%)4.1% (95% CI 4.0%–4.3%)
  • Concomitant gabapentinoid and opioid prescribing: P < .001

Postoperative opioid prescribing · same period as gabapentinoid trend

Opioid prescribing increased in the same period
56% (95% CI, 55%-56%) to 59% (95% CI, 58%-60%)
  • P < .001

Variation by procedure type

Variation between procedure types; almost all procedures saw an increase in both gabapentinoid and opioid prescribing

Original publication

Trends in the Use of Gabapentinoids and Opioids in the Postoperative Period Among Older Adults. JAMA Netw Open. Published 1 June 2023. doi:10.1001/jamanetworkopen.2023.18626

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.